These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9732143)

  • 1. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
    Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
    Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococcus faecium: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against multiple-antibiotic-resistant strains.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):254-64. PubMed ID: 8325127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies.
    Traub WH; Geipel U; Schwarze I; Bauer D
    Chemotherapy; 1999; 45(5):349-59. PubMed ID: 10473923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
    Vartivarian S; Anaissie E; Bodey G; Sprigg H; Rolston K
    Antimicrob Agents Chemother; 1994 Mar; 38(3):624-7. PubMed ID: 8203865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.
    Krueger TS; Clark EA; Nix DE
    Diagn Microbiol Infect Dis; 2001; 41(1-2):71-8. PubMed ID: 11687317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Ismaeel NA
    Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
    Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
    J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
    Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
    J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
    Penzak SR; Abate BJ
    Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
    Smit WJ; Boquest AL; Geddes JE; Tosolini FA
    Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia.
    Muñoz JL; García MI; Muñoz S; Leal S; Fajardo M; Garćia-Rodríguez JA
    Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):879-82. PubMed ID: 8997563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.